Patent details

Basic Information

Publication number:

EP2568285

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121952535

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

French Title of Invention:

ESSAIS D'ACTIVITÉ ENDOPEPTIDASE RECIBLÉE IMMUNOLOGIQUE

German Title of Invention:

IMMUNOBASIERTE NEU AUSGERICHTETE ENDOPEPTIDASEAKTIVITÄTSTESTS

SPC Number:

Dates

Filing date:

12/03/2010

Grant date:

25/12/2019

EP Publication Date:

13/03/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/12/2019

EP B1 Publication Date:

25/12/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/03/2020

Expiration date:

12/03/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/12/2019

 

 

Name:

ALLERGAN, INC.

Address:

2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:

Wang, Joanne

Address:

United States (US)

2

Name:

Zhu, Hong

Address:

United States (US)

3

Name:

Fernandez-Salas, Ester

Address:

United States (US)

4

Name:

Hodges, D. Diane

Address:

United States (US)

Priority

Priority Number:

160217 P

Priority Date:

13/03/2009

Priority Country:

United States (US)

Classification

IPC classification:

C12Q 1/37; G01N 33/50;

Publication

European Patent Bulletin

Issue number:

201952

Publication date:

25/12/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages